SCHEMBL8530835

SCHEMBL8530835

COc1cc2c(O)cc(C(C)(C)O)c(-c3ccc(C(C)(C)C)cc3)c2cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR2 P21802 3/20 0.40
HPGD P15428 2/20 0.40
ALOX15 P16050 2/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
TDO2 P48775 1/20 0.36
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
TRPV1 Q8NER1 2/20 0.34
KLK7 P49862 1/20 0.33
RAB9A P51151 1/20 0.33
GCGR P47871 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
RAC1 P63000 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3961375 0.90 IDO1 (0.41) HPGDALOX15LMNATP53CYP3A4
SCHEMBL1009822 0.86 SLC2A1 (0.39) HPGDALOX15LMNATP53CYP3A4
SCHEMBL6823069 0.86 PDE4B (0.41) HPGDALOX15LMNATP53CYP3A4
SCHEMBL8531421 0.78 MAPT (0.45) FGFR2HPGDLMNATP53ALDH1A1
SCHEMBL30662430 0.75 MAPT (0.44) FGFR2HPGDLMNACYP3A4TDO2
SCHEMBL3947944 0.74 CSNK2A2 (0.39) LMNATP53ALDH1A1MAPTCNR1
SCHEMBL9898544 0.72 KCNA5 (0.41) HPGDTP53CYP3A4ALDH1A1MAPT
SCHEMBL30125445 0.72 CNR1 (0.35) FGFR2TDO2GAACNR1CNR2
SCHEMBL8509708 0.72 CNR1 (0.35) FGFR2TDO2GAACNR1CNR2
SCHEMBL9934896 0.70 ANTXR2 (0.39) HPGDTP53CYP3A4ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139552-B2 Indeno-fused naphthopyrans having ethylenically unsaturated groups TRANSITIONS OPTICAL, INC. (US) 2015-09-22 US disclosed
WO-2013090220-A1 INDENO-FUSED NAPHTHOPYRANS HAVING ETHYLENICALLY UNSATURATED GROUPS PPG INDUSTRIES, INC. (US) 2013-06-20 WO disclosed
US-20120132870-A1 Indeno-Fused Naphthopyrans Having Ethylenically Unsaturated Groups TRANSITIONS OPTICAL INC. (US) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132870-A1 Indeno-Fused Naphthopyrans Having Ethylenically Unsaturated Groups ACR, INTS6, B3GNT2 FGFR2 1603/4885HPGD 267/4885ALOX15 637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.